Pediatric Onco-Hematology, Regina Margherita Children's Hospital, Turin, Italy.
Haematologica. 2012 Dec;97(12):1813-7. doi: 10.3324/haematol.2012.062281. Epub 2012 Jun 11.
Diamond-Blackfan anemia is an autosomal dominant disease due to mutations in nine ribosomal protein encoding genes. Because most mutations are loss of function and detected by direct sequencing of coding exons, we reasoned that part of the approximately 50% mutation negative patients may have carried a copy number variant of ribosomal protein genes. As a proof of concept, we designed a multiplex ligation-dependent probe amplification assay targeted to screen the six genes that are most frequently mutated in Diamond-Blackfan anemia patients: RPS17, RPS19, RPS26, RPL5, RPL11, and RPL35A. Using this assay we showed that deletions represent approximately 20% of all mutations. The combination of sequencing and multiplex ligation-dependent probe amplification analysis of these six genes allows the genetic characterization of approximately 65% of patients, showing that Diamond-Blackfan anemia is indisputably a ribosomopathy.
Diamond-Blackfan 贫血是一种常染色体显性疾病,由九个核糖体蛋白编码基因的突变引起。由于大多数突变是功能丧失性的,并且可以通过编码外显子的直接测序检测到,因此我们推测大约 50%的突变阴性患者可能携带核糖体蛋白基因的拷贝数变异。作为概念验证,我们设计了一种多重连接依赖性探针扩增检测,靶向筛选 Diamond-Blackfan 贫血患者中最常发生突变的六个基因:RPS17、RPS19、RPS26、RPL5、RPL11 和 RPL35A。使用该检测方法,我们发现缺失约占所有突变的 20%。对这六个基因进行测序和多重连接依赖性探针扩增分析的组合可以对大约 65%的患者进行基因特征分析,表明 Diamond-Blackfan 贫血确实是一种核糖体病。